Shillong, Nov 23 (UNI) Meghalaya government has identified 25,000 healthcare care
workers for providing assistance in the vaccination process of COVID-19 when the
vaccine is made available to the State, health officials said on Monday
The Union Ministry of Health and Family Welfare have sent a directive to the State
governments to identify health workers in advance.
Health officials said that the identified health care workers in the State, who would be
covered in the first phase of vaccination, are both from the public and private sector for
the smooth vaccination process.
"The whole exercise of vaccination will be taken up in a phase-wise manner. The
Union Government is yet to communicate the decision on the vaccine that is supposed
to be administered," the Health official said.
Recently, the State Task Force Meeting for COVID-19 Vaccine was held under the
chairmanship of Commissioner & Secretary Health & Family Welfare, Sampath Kumar
to take advance and preparatory steps to introduce the COVID-19 Vaccine in the state.
The meeting was also attended by the Mission Director NHM, Director Health Services
Research, representatives from Social Welfare Department, Urban Affairs Department,
United Nations Development Programme, World Health Organization, various religious
organizations, officials from the health department and NHM.
In the meeting all inputs and suggestions given by the various representatives were
noted. They expected that the roll out of COVID-19 Vaccine would be smooth and
successful.
"Considering the magnitude of the exercise, advance planning and preparation is
necessary. Hence, the task force had met to decide on the modalities of implementation,"
Health officials said.
The Union Government is yet to communicate the decision on the vaccine that is
supposed to be administered, the State health officials said.
As of now, the Oxford-AstraZeneca vaccine looks the most promising with 70- to 90
percent effectiveness against the virus without any serious side effects in the trial phase.
It is also one of the cost-effective vaccines.
UNI RRK BM